Related Experiment Videos
[Inflammatory changes and immunological disturbances in stroke]
1II Kliniki Neurologii Instytutu Psychiatrii i Neurologii w Warszawie.
Neurologia I Neurochirurgia Polska
|August 27, 1999
Summary
Activated leukocytes contribute to brain damage after stroke by causing inflammation and releasing neurotoxins. Therapies reducing these immune responses show promise in treating experimental brain stroke.
Area of Science:
- Neuroscience
- Immunology
- Cerebrovascular disease
Context:
- Activated leukocytes and glial cells contribute to ischemic brain injury.
- Cytokine production by these cells upregulates adhesion molecules, promoting inflammatory cell accumulation.
- Leukocytes and glial cells release neurotoxic substances like free radicals and nitric oxide.
Purpose:
- To explore the role of activated leukocytes in microcirculatory disturbances and ischemic brain damage.
- To investigate the contribution of astrocytes, microglia, and endothelial cells to ischemic evolution.
- To discuss therapeutic strategies targeting inflammatory and immunological responses in experimental stroke.
Summary:
- Activated leukocytes exacerbate ischemic stroke by impairing microcirculation and expanding necrosis.
- Astrocytes, microglia, and endothelial cells actively participate in ischemic changes, releasing inflammatory mediators and neurotoxins.
- Pre-stroke infections can heighten leukocyte activation and intensify the inflammatory process in the ischemic focus.
- The paper reviews experimental stroke treatments aimed at mitigating inflammatory and immunological responses.
Impact:
- Highlights the critical role of the inflammatory and immune response in ischemic stroke pathogenesis.
- Identifies key cellular players and molecular mechanisms involved in brain injury progression.
- Suggests potential therapeutic targets for reducing brain damage and improving outcomes after stroke.